ask why

Latest research

Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.

Urology · World J Urol · 2026-09-28

In a systematic review of 18 trials (16 network meta-analysed) of add-on therapy for persistent overactive bladder symptoms in α1-blocker-treated men with BPH, vibegron cut micturitions (−0.81/24 h) and urgency versus control; no clear advantage over mirabegron was shown.

Meta-analysisn = 18 trials
Yajima et al. Vibegron, mirabegron, and other add-on therapies for persistent overactive bladder symptoms in α1-blocker-treated men with benign prostatic hyperplasia: a systematic review and Bayesian network meta-analysis

Sign in to react

Enter your email and we send a 6-digit code and a link. No password.

Your name and role

These appear beside any methods concern you post and on your profile page.